No Data
No Data
Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development
Novartis: Current Chief Ethics, Risk & Compliance Officer Klaus Moosmayer to Step Down
Novartis Appoints Karen Hale, Chief Legal and Compliance Officer
Novartis Obtains US FDA Approval for Prostate Cancer Medication Pluvicto
SA Asks: What Are the Best Large-cap Cardiology Stocks Right Now?
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms